229 related articles for article (PubMed ID: 9786372)
1. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
Rahal JJ; Urban C; Horn D; Freeman K; Segal-Maurer S; Maurer J; Mariano N; Marks S; Burns JM; Dominick D; Lim M
JAMA; 1998 Oct; 280(14):1233-7. PubMed ID: 9786372
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.
Meyer KS; Urban C; Eagan JA; Berger BJ; Rahal JJ
Ann Intern Med; 1993 Sep; 119(5):353-8. PubMed ID: 8135915
[TBL] [Abstract][Full Text] [Related]
3. Sequential emergence of multi-resistant Klebsiella pneumoniae in Bahrain.
Wallace MR; Johnson AP; Daniel M; Malde M; Yousif AA
J Hosp Infect; 1995 Dec; 31(4):247-52. PubMed ID: 8926374
[TBL] [Abstract][Full Text] [Related]
4. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Wiener J; Quinn JP; Bradford PA; Goering RV; Nathan C; Bush K; Weinstein RA
JAMA; 1999 Feb; 281(6):517-23. PubMed ID: 10022107
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections].
Ivanov DV
Antibiot Khimioter; 2006; 51(11-12):29-36. PubMed ID: 18318145
[TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
Bisson G; Fishman NO; Patel JB; Edelstein PH; Lautenbach E
Infect Control Hosp Epidemiol; 2002 May; 23(5):254-60. PubMed ID: 12026150
[TBL] [Abstract][Full Text] [Related]
7. Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit.
Bassetti M; Righi E; Ansaldi F; Molinari MP; Rebesco B; McDermott JL; Fasce R; Mussap M; Icardi G; Bobbio Pallavicini F; Viscoli C
J Chemother; 2009 Dec; 21(6):633-8. PubMed ID: 20071286
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.
Lee SC; Fung CP; Liu PY; Wang TC; See LC; Lee N; Chen SC; Shieh WB
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):205-7. PubMed ID: 10100550
[TBL] [Abstract][Full Text] [Related]
9. Restriction of third-generation cephalosporin use decreases infection-related mortality.
Du B; Chen D; Liu D; Long Y; Shi Y; Wang H; Rui X; Cui N
Crit Care Med; 2003 Apr; 31(4):1088-93. PubMed ID: 12682477
[TBL] [Abstract][Full Text] [Related]
10. Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Kim JY; Sohn JW; Park DW; Yoon YK; Kim YM; Kim MJ
J Antimicrob Chemother; 2008 Aug; 62(2):416-21. PubMed ID: 18413317
[TBL] [Abstract][Full Text] [Related]
11. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
12. Comparative susceptibilities of Klebsiella species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospital.
Fekete T; Tumah H; Woodwell J; Satishchandran V; Truant A; Axelrod P
Am J Med; 1996 Jun; 100(6A):20S-25S. PubMed ID: 8678093
[TBL] [Abstract][Full Text] [Related]
13. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
Cook PP; Das TD; Gooch M; Catrou PG
Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
15. [Imipenem resistance in Pseudomonas aeruginosa].
Fille M; Bauernfeind A; Eberlein E; Jungwirth R; Schneider I; Speer G; Dierich MP; Allerberger F
Wien Klin Wochenschr; 1998 Oct; 110(20):715-20. PubMed ID: 9857429
[TBL] [Abstract][Full Text] [Related]
16. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.
Kochar S; Sheard T; Sharma R; Hui A; Tolentino E; Allen G; Landman D; Bratu S; Augenbraun M; Quale J
Infect Control Hosp Epidemiol; 2009 May; 30(5):447-52. PubMed ID: 19301985
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital.
Jean SS; Teng LJ; Hsueh PR; Ho SW; Luh KT
J Antimicrob Chemother; 2002 Jan; 49(1):69-76. PubMed ID: 11751769
[TBL] [Abstract][Full Text] [Related]
18. Increasing burden of hospital acquired infections: resistance to cephalosporin antibiotics among klebsiella and Escherichia coli.
Patil A; Krishna BV; Chandrasekhar MR
J Indian Med Assoc; 2011 Mar; 109(3):158-60. PubMed ID: 22010583
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP
Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392
[TBL] [Abstract][Full Text] [Related]
20. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Spencer RC
Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
